FDA Approved: AMBRISENTAN — Original Application (Sigmapharm Laboratories, LLC)

View source ↗

Summary

FDA approved a generic version of ambrisentan (original application) from Sigmapharm Laboratories for pulmonary arterial hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Ambrisentan (Ambrisentan)

Snippet

ORIG AP for AMBRISENTAN (AMBRISENTAN)